Cargando…

Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma

Multiple myeloma is a malignant clonal proliferation of plasma cells in the bone marrow preceded by monoclonal gammopathy of undetermined significance. Initial presentation of multiple myeloma as extramedullary spread in soft tissues particularly in the liver is uncommon. We report a case of a 74-ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiu, Andrew C., Potdar, Rashmika, Arguello-Gerra, Vivian, Morginstin, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994292/
https://www.ncbi.nlm.nih.gov/pubmed/29977630
http://dx.doi.org/10.1155/2018/7954816
_version_ 1783330415008808960
author Tiu, Andrew C.
Potdar, Rashmika
Arguello-Gerra, Vivian
Morginstin, Mark
author_facet Tiu, Andrew C.
Potdar, Rashmika
Arguello-Gerra, Vivian
Morginstin, Mark
author_sort Tiu, Andrew C.
collection PubMed
description Multiple myeloma is a malignant clonal proliferation of plasma cells in the bone marrow preceded by monoclonal gammopathy of undetermined significance. Initial presentation of multiple myeloma as extramedullary spread in soft tissues particularly in the liver is uncommon. We report a case of a 74-year-old African American female who presented with epigastric pain, hematemesis, elevated alkaline phosphatase, and gamma-glutamyl transferase. Initial impression was peptic ulcer disease; however, ultrasound and CT scan of the abdomen showed multiple liver nodules and perihepatic lymphadenopathy suggestive of metastatic disease. Biopsy of the liver nodules showed CD138 and kappa light chain-restricted positive cells consistent with extramedullary spread of multiple myeloma to the liver. The patient achieved partial response after 6 months of treatment with Velcade, cyclophosphamide, and dexamethasone (VCD). Due to severe neutropenia from cyclophosphamide, regimen was switched to Velcade, Revlimid, and dexamethasone (VRD) which resulted to very good partial response in 1 year which eventually persisted after 4 years. No controlled prospective studies have defined the standard treatment for multiple myeloma with extramedullary spread particularly to the liver. Treatment of multiple myeloma with extramedullary disease follows guidelines for multiple myeloma.
format Online
Article
Text
id pubmed-5994292
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-59942922018-07-05 Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma Tiu, Andrew C. Potdar, Rashmika Arguello-Gerra, Vivian Morginstin, Mark Case Rep Hematol Case Report Multiple myeloma is a malignant clonal proliferation of plasma cells in the bone marrow preceded by monoclonal gammopathy of undetermined significance. Initial presentation of multiple myeloma as extramedullary spread in soft tissues particularly in the liver is uncommon. We report a case of a 74-year-old African American female who presented with epigastric pain, hematemesis, elevated alkaline phosphatase, and gamma-glutamyl transferase. Initial impression was peptic ulcer disease; however, ultrasound and CT scan of the abdomen showed multiple liver nodules and perihepatic lymphadenopathy suggestive of metastatic disease. Biopsy of the liver nodules showed CD138 and kappa light chain-restricted positive cells consistent with extramedullary spread of multiple myeloma to the liver. The patient achieved partial response after 6 months of treatment with Velcade, cyclophosphamide, and dexamethasone (VCD). Due to severe neutropenia from cyclophosphamide, regimen was switched to Velcade, Revlimid, and dexamethasone (VRD) which resulted to very good partial response in 1 year which eventually persisted after 4 years. No controlled prospective studies have defined the standard treatment for multiple myeloma with extramedullary spread particularly to the liver. Treatment of multiple myeloma with extramedullary disease follows guidelines for multiple myeloma. Hindawi 2018-05-24 /pmc/articles/PMC5994292/ /pubmed/29977630 http://dx.doi.org/10.1155/2018/7954816 Text en Copyright © 2018 Andrew C. Tiu et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tiu, Andrew C.
Potdar, Rashmika
Arguello-Gerra, Vivian
Morginstin, Mark
Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma
title Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma
title_full Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma
title_fullStr Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma
title_full_unstemmed Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma
title_short Multiple Liver Nodules Mimicking Metastatic Disease as Initial Presentation of Multiple Myeloma
title_sort multiple liver nodules mimicking metastatic disease as initial presentation of multiple myeloma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994292/
https://www.ncbi.nlm.nih.gov/pubmed/29977630
http://dx.doi.org/10.1155/2018/7954816
work_keys_str_mv AT tiuandrewc multiplelivernodulesmimickingmetastaticdiseaseasinitialpresentationofmultiplemyeloma
AT potdarrashmika multiplelivernodulesmimickingmetastaticdiseaseasinitialpresentationofmultiplemyeloma
AT arguellogerravivian multiplelivernodulesmimickingmetastaticdiseaseasinitialpresentationofmultiplemyeloma
AT morginstinmark multiplelivernodulesmimickingmetastaticdiseaseasinitialpresentationofmultiplemyeloma